Form 4: Pacira BioSciences Executive Kristen Williams Reports Acquisition of Restricted Stock Units

Kristen Williams, Chief Administrative Officer of Pacira BioSciences, reports the acquisition of 79,200 restricted stock units.

Summary

• On February 1, 2025, Kristen Williams, Chief Administrative Officer of Pacira BioSciences, acquired 79,200 restricted stock units.
• These restricted stock units vest in four equal annual installments starting February 1, 2026, contingent upon continuous service with the issuer.
• Each restricted stock unit represents the right to receive one share of Pacira BioSciences' common stock.
• Following the transaction, Williams beneficially owns 182,112 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted stock units is a common practice and aligns executive interests with shareholder value. There are no explicit negative indicators.

Positives

• The acquisition of restricted stock units aligns the executive's interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the Chief Administrative Officer.

Future Outlook

The vesting of the restricted stock units is contingent upon the reporting person's continued service with the issuer.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive can positively influence shareholder confidence.
• The vesting schedule incentivizes the executive to remain with the company, which benefits employees and other stakeholders.

Key Dates

Keywords

Pacira BioSciences, Kristen Williams, restricted stock units, Form 4, beneficial ownership, PCRX, executive compensation